Anavex Life Sciences Corporation

NASDAQ:AVXL   3:59:53 PM EDT
11.34
-0.27 (-2.33%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Anavex Life Sciences Corporation Stock, NASDAQ:AVXL

51 West 52nd Street, 7th floor, New York, New York 10019-6163
United States of America
Phone: +1.800.689.3939
Number of Employees: 20

Description

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.